Uptake of COVID-19 Booster Dose among Saudi Arabian Population

Alshahrani, Najim Z.; Alsabaani, Abdullah; Ridda, Iman; Rashid, Harunor; Alzahrani, Faris; Almutairi, Talal Hamed; Alzahrani, Bader Ahmed S.; Albeshri, Abdulelah Saleh Saeed

doi:10.3390/medicina58070972

Cited by 16 publications

(14 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is confirmed by our present study. Studies have also described that vaccine uptake increases with age, which also correlates positively with our study (33)(34)(35)(36).…”

Section: Discussionsupporting

confidence: 90%

First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease—a cross-sectional survey in Hungary

Fekete¹,

Horváth²,

Santa³

et al. 2023

Ann Palliat Med

View full text Add to dashboard Cite

Background: In chronic obstructive pulmonary disease (COPD), uptake of the coronavirus disease 2019 (COVID-19) booster vaccine is important, as they are more likely to develop serious complications. Our aim was to investigate the uptake rate of first booster vaccination against COVID-19 among COPD patients and to identify other related factors of vaccine uptake. Methods: We conducted a multicenter survey of COPD patients in Hungary by region: eastern, western and central ones from 15 November 2021. Respiratory function test results, anthropometric data and vaccination status were recorded for 1510 randomly selected patients over 35 years of age. Multiple logistic regression analysis was used to determine factors associated with uptake of COVID-19 first booster dose vaccines.Results: The average age was 67 [61-72] years, for men it was: 67 [62-73] and 66 [60-72] years for women, with a sample of 47.95% men and 52.05% women. The uptake rate of the COVID-19 first booster vaccine during the study period was 62.45%. Comparing patients who received the 3rd vaccine with those who did not receive the 3rd vaccine, the difference was significant in quality of life: COPD Assessment Test (CAT):16 [11][12][13][14][15][16][17][18][19][20][21] vs. 14 [10-19], P<0.001, modified Medical Research Council (mMRC) dyspnea scale: 2 [2-2] vs. 2 [1-2], P=0.01 and in the number of moderate exacerbations: 1 [0-1] vs. 0 [0-1], P=0.04. In addition, who did not take the third vaccination significantly more people were hospitalized for acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (16 vs. 0, P<0.001) and almost the same proportion (n=14) required pulmonary outpatient rehabilitation for post-COVID symptoms. The factors that were most associated with higher COVID-19 vaccine first booster dose uptake were older age [odds ratio (OR): 1.06; 95% confidence interval (CI): 1.04-1.08], male gender (OR: 0.74; 95% CI: 0.57-0.96), absence of previous COVID-19 infection (OR: 0.34; 95% CI: 0.23-0.51). Conclusions:The uptake rate of the COVID-19 booster vaccine among COPD patients in Hungary is lower than the target, and is associated with disease-related factors, and age, sex, previous COVID infection.The global COVID-19 vaccination target is 70% and 100% for elderly, vulnerable patients. Highlighting the importance of taking booster vaccine(s) should be a priority for health workers.

show abstract

“…This is confirmed by our present study. Studies have also described that vaccine uptake increases with age, which also correlates positively with our study (33)(34)(35)(36).…”

Section: Discussionsupporting

confidence: 90%

First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease—a cross-sectional survey in Hungary

Fekete¹,

Horváth²,

Santa³

et al. 2023

Ann Palliat Med

View full text Add to dashboard Cite

show abstract

“…Participants in the original survey were asked about their gender, education, and testing positive for COVID-19 in the last year; a standard set of measures in studies examining COVID-19 vaccine uptake. The survey also included questions measuring partisan self-identification, trust in physicians, and evangelical Christian identity, which have been linked to COVID-19 vaccine hesitancy [ 6 , 13 ].…”

Section: Methodsmentioning

confidence: 99%

“…Booster uptake amongst older adults has not been thoroughly studied despite this population being at greater risk from COVID-19. Most studies that examine attitudes toward COVID-19 booster vaccination were based on samples of the general population [6] , [7] , [8] . The few studies that examined booster uptake among older adults provided mixed findings.…”

Section: Introductionmentioning

confidence: 99%

“…Existing studies showed that booster uptake among older adults was positively associated with higher social cohesion [9] , higher sense of control [10] , and positive attitudes towards a booster dose [11] . Yet, some studies showed that individuals with low trust in doctors are less likely to receive the initial dose of COVID-19 vaccination [12] as well as booster doses [6] . Therefore, we seek to examine whether trust in physicians affects COVID-19 booster uptake among older adults.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Trust in physicians predicts COVID-19 booster uptake among older adults: Evidence from a panel survey

Viskupič

Wiltse

2023

Aging and Health Research

View full text Add to dashboard Cite

“…[12] Moreover, educating the population about the risks requires much effort, as shown by the lack of awareness and slow uptake of the COVID-19 booster dose in Saudi Arabia. [13] Early studies suggest that when it comes to MPX, there is a lack of sufficient knowledge about the disease in the general population and healthcare workers. Even though the public health threat posed by MPX remains moderately high.…”

Section: Introductionmentioning

confidence: 99%

Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?

Alarifi¹,

Alshahrani²,

Sah³

2022

Preprint

View full text Add to dashboard Cite

Early experience with Covid-19 shows that vaccines can be the most effective way of preventing the spread of infection. However, vaccine hesitancy is among the most significant hurdles in preventing the spread of novel infections. Monkeypox (MPX) has already been declared a global health emergency by WHO. Thus, there is an urgent need to understand the MPX vaccine willingness in various population groups. In this cross-sectional study, an online survey was conducted among Saudi healthcare workers (HCWs) to understand the monkeypox vaccine willingness in healthcare workers in Saudi Arabia. Saudi has already confirmed multiple MPX cases, and thus it is essential to initiate timely protective measures, including vaccination. The study had 743 respondents. The study found that among Saudi HCWs, 52.7% were willing to receive the MPX vaccine. The study found that sociodemographic factors had a small impact on vaccine willingness. However, early experience with vaccination had a significant impact. Thus, more than 70% who had influenza or COVID-19 vaccine were willing to receive the MPX vaccine. Some of the most significant concerns influencing vaccine acceptability were the safety and efficacy of the vaccine. Hence, it is strongly recommended to focus on disseminating information regarding the safety and efficacy of the MPX vaccine.

show abstract

Uptake of COVID-19 Booster Dose among Saudi Arabian Population

Cited by 16 publications

References 32 publications

First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease—a cross-sectional survey in Hungary

First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease—a cross-sectional survey in Hungary

Trust in physicians predicts COVID-19 booster uptake among older adults: Evidence from a panel survey

Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?

Contact Info

Product

Resources

About